V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 320005629 | 320003975 | 1.87 | 74.5 | Neo-adjuvant (N) | null | 2016-02-03 | NIVOLUMAB | N | null | 320023226 | CARBOPLATIN + ETOPOSIDE |
| 320005630 | 320003975 | 1.61 | 61 | Curative (C) | 2015-03-13 | 2015-03-25 | PEMBROLIZUMAB | Y | N | 320023226 | PEMBROLIZUMAB |
| 320005631 | 320003975 | 1.61 | 68.75 | Not known (9) | 2017-05-08 | 2017-05-08 | Bevacizumab + CARBOPLATIN + PACLITAXEL | Y | N | 320023226 | ICON TRIAL |
| 320005632 | 320003976 | 1.74 | 80.55 | Curative (C) | 2017-08-14 | 2017-08-27 | CAP | 02 | N | 320023251 | RMS 2005 TRIAL |
| 320005633 | 320003976 | 0 | 88 | Neo-adjuvant (N) | 2015-11-17 | 2015-11-20 | Bevacizumab+Carbo+Pacliaxel | N | N | 320023251 | BCG |
| 320005634 | 320003978 | 1.72 | 63.5 | Palliative (P) | 2019-05-02 | 2019-10-04 | CARBOPLATIN + RT | 01 | N | 320023270 | CARBOPLATIN + RT |
| 320005635 | 320003979 | 1.76 | 70.4 | Palliative (P) | null | 2015-09-27 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 320023276 | CARBOPLATIN + CETUXIMAB + FU |
| 320005636 | 320003981 | 1.64 | null | Curative (C) | 2014-10-26 | 2014-11-04 | CARBOPLATIN + ETOPOSIDE | N | N | 320023279 | BCG |
| 320005637 | 320003981 | null | 74.7 | Palliative (P) | 2016-02-14 | 2016-03-09 | TCF | null | null | 320023279 | CARBOPLATIN + RT |
| 320005638 | 320003981 | 1.71 | 73.8 | Palliative (P) | 2018-07-07 | 2018-07-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 320023279 | CETUXIMAB + OXALIPLATIN + MDG |
| 320005639 | 320003982 | 1.45 | 55.1 | Palliative (P) | 2016-10-04 | 2017-12-09 | Bevacizumab+Carbo+Pacliaxel | N | N | 320023297 | VINBLASTINE |
| 320005640 | 320003982 | 1.8 | 86.2 | Adjuvant (A) | 2017-02-11 | 2017-03-05 | TEMOZOLOMIDE | 02 | Y | 320023297 | CARBOPLATIN + RT |
| 320005641 | 320003983 | 0 | 66 | Palliative (P) | 2014-11-28 | 2014-11-28 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 320023311 | CETUXIMAB + RT |
| 320005642 | 320003984 | 1.68 | 87.1 | Palliative (P) | 2015-01-20 | 2015-01-28 | VINCRISTINE | N | N | 320023313 | TEMOZOLOMIDE |
| 320005643 | 320003985 | 1.82 | 80 | Palliative (P) | 2018-06-22 | 2018-07-17 | Carboplatin + Etoposide IV 3 day | N | N | 320023333 | POUT TRIAL |
| 320005644 | 320003985 | 1.71 | 0 | Palliative (P) | 2013-12-29 | 2014-01-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 320023333 | TRIFLURIDINE + TIPIRACIL |
| 320005645 | 320003986 | null | 67.8 | Palliative (P) | 2014-02-03 | 2014-02-09 | Cisplatin + Paclitaxel | N | N | 320023358 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320005646 | 320006705 | 1.52 | 76 | null | 2014-01-04 | 2014-01-14 | POMALIDOMIDE | N | N | 320023361 | CISPLATIN + VINORELBINE |
| 320005647 | 320003987 | 1.65 | 67.4 | Palliative (P) | 2015-02-02 | 2015-02-02 | Bevacizumab+Carbo+Pacliaxel | 02 | N | 320023373 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005648 | 320003987 | 1.86 | 91.5 | Palliative (P) | 2014-07-21 | 2014-07-21 | CETUXIMAB + RT | Y | N | 320023373 | PEMBROLIZUMAB |
| 320005649 | 320003989 | 1.61 | 54.6 | Palliative (P) | 2015-09-08 | 2015-09-14 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 320023380 | ICON8B TRIAL |
| 320005650 | 320005832 | 1.62 | 56 | Curative (C) | 2011-03-13 | 2013-08-08 | CNS LGG 2004 03 vinc weekly+ carbo | N | 2 | 320023393 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 320005651 | 320003992 | 1.73 | null | Palliative (P) | 2016-12-24 | 2017-02-01 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | Y | 320023395 | CARBOPLATIN + RT |
| 320005652 | 320003992 | 1.56 | 33.5 | Curative (C) | 2015-11-18 | 2015-12-02 | EOX | null | null | 320023395 | TRABECTEDIN |
| 320005653 | 320006708 | 1.45 | null | Palliative (P) | 2016-05-26 | 2016-06-01 | Carbo F | N | null | 320023433 | IPILIMUMAB |
| 320005654 | 320006708 | 1.8 | 71.4 | Curative (C) | 2015-12-18 | 2015-12-25 | Carbo F | N | N | 320023433 | CETUXIMAB + CISPLATIN + FU |
| 320005655 | 320006708 | 1.64 | 59.5 | Palliative (P) | 2019-03-03 | 2019-03-07 | Carboplatin + Cetux + FU (>Cycle 2) | 01 | N | 320023433 | EPIRUBICIN |
| 320005656 | 320006708 | 1.59 | 105.4 | Palliative (P) | null | 2015-10-21 | Etoposide oral | null | null | 320023433 | GEMCITABINE |
| 320005657 | 320003993 | null | null | Palliative (P) | 2016-05-10 | 2016-05-30 | CARBOPLATIN + RT | N | N | 320023474 | DOCETAXEL |
| 320005658 | 320003994 | 1.59 | null | Palliative (P) | 2016-09-22 | 2016-09-30 | CAPECITABINE + OXALIPLATIN | N | N | 320023477 | CAPECITABINE |
| 320005659 | 320003995 | null | 76.1 | Curative (C) | 2017-09-17 | 2017-11-14 | CNS GCT II Germinoma - Carbo Etop | Y | N | 320023480 | RMS 2005 TRIAL |
| 320005660 | 320003995 | 1.59 | 63.5 | Palliative (P) | 2015-03-26 | 2015-03-28 | Bevacizumab+Carbo+Pacliaxel | null | null | 320023480 | ICON8B TRIAL |
| 320005661 | 320003996 | 1.71 | 89.4 | Adjuvant (A) | 2017-09-05 | 2017-09-05 | Y-90 | 02 | N | 320023496 | TEMOZOLOMIDE |
| 320005662 | 320003997 | 1.48 | 51.7 | Not known (9) | 2016-05-01 | 2016-05-10 | Fluorouracil PVI + Mitomycin 42 day | 2 | N | 320023507 | TOPOTECAN |
| 320005663 | 320004000 | 1.89 | 74 | Palliative (P) | null | 2014-02-11 | Vemurafenib | null | null | 320023510 | AFLIBERCEPT + FU + IRINOTECAN |
| 320005665 | 320004003 | 1.73 | 103 | Curative (C) | 2017-09-16 | 2017-09-24 | Capecitabine + Oxaliplatin 21day | 2 | N | 320023538 | NIVOLUMAB |
| 320005666 | 320004006 | 1.65 | null | Curative (C) | 2015-03-05 | 2016-09-30 | EMA | N | null | 320023538 | POUT TRIAL |
| 320005667 | 320006710 | 1.46 | 59 | Adjuvant (A) | 2014-12-13 | 2015-01-04 | Bevacizumab+Carbo+Pacliaxel | N | N | 320023562 | CETUXIMAB + CISPLATIN + FU |
| 320005668 | 320004009 | 1.73 | 81.1 | Adjuvant (A) | null | 2015-07-25 | TCF | N | N | 320023577 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005669 | 320004010 | null | 61.4 | Curative (C) | 2015-02-23 | 2015-02-23 | Vinblastine | 02 | Y | 320023596 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 320005670 | 320004010 | 1.69 | null | Disease modification (D) | null | 2018-03-10 | Capecitabine | null | null | 320023596 | DOCETAXEL |
| 320005671 | 320004012 | 1.77 | null | Palliative (P) | 2018-06-09 | 2018-06-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 320023627 | CARBOPLATIN + RT |
| 320005672 | 320004013 | 1.6 | 94.6 | Palliative (P) | 2013-08-24 | 2013-09-28 | STS Rhabdo VIT0910 Vinc Irinotecan | N | N | 320023661 | CETUXIMAB + CISPLATIN + FLUOROURACIL |
| 320005673 | 320004014 | 1.73 | 63.7 | Palliative (P) | 2016-08-07 | 2016-09-06 | Cetuximab + Radiotherapy Maint | N | N | 320023661 | PCV |
| 320005674 | 320005843 | 1.66 | 97 | Disease modification (D) | 2013-04-24 | 2014-05-18 | NIVOLUMAB | N | N | 320023680 | IVA |
| 320005676 | 320004019 | 1.6 | 55 | Curative (C) | 2014-01-27 | 2014-03-03 | POUT TRIAL | N | N | 320023682 | TRASTUZUMAB |
| 320005677 | 320004021 | 1.78 | null | Palliative (P) | 2016-12-04 | 2017-02-24 | Carboplatin + Cetuximab (>Cycle 2) | null | null | 320023684 | OXALIPLATIN + MDG |
| 320005680 | 320004023 | null | 84 | Adjuvant (A) | 2016-10-12 | 2017-02-20 | TEMOZOLOMIDE | N | N | 320023697 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 320005681 | 320004025 | 1.79 | 78.4 | Palliative (P) | 2017-09-04 | 2017-09-26 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | null | 320023703 | CAPE + CARBOPLATIN + CETUXIMAB |
| 320005682 | 320004026 | 1.61 | 93.8 | Neo-adjuvant (N) | null | 2014-12-20 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | N | 320023706 | CAV |